Elevance Health 的盈利超出预期，但由于医疗保险成本上升，利润下降，导致股价下跌。 Elevance Health beat earnings expectations but saw profit drop due to rising Medicare costs, prompting a stock decline.

Elevance Health 公布了 2025 年第三季度业绩，营收为 507.1 亿美元，同比增长 12.4%，调整后每股收益为 6.03 美元，超出预期。 Elevance Health reported third-quarter 2025 results with revenue of $50.71 billion, up 12.4% year-over-year, and adjusted earnings of $6.03 per share, exceeding expectations. 尽管收入丰厚,但该公司的营业利润急剧下降,因为医疗费用上升,特别是在医疗保健部门,导致调整后的每股收入从8.37美元下降到6.03美元。 Despite strong revenue and earnings, the company’s operating profit dropped sharply due to rising medical costs, especially in Medicare, leading to a decline in adjusted earnings per share from $8.37 to $6.03. 由于美国商务部对医疗设备进口的调查引起了更广泛的担忧,该股票在新闻发布后下跌了3.2%,尽管该公司重申了全年每股30美元的利预期. The stock fell 3.2% on the news, amid broader concerns over a U.S. Commerce Department investigation into medical equipment imports, though the company reaffirmed its full-year earnings guidance of $30 per share.